This finding is significant, as elevated levels of TNF-α, interferon gamma (IFN-γ), and interleukin 6 (IL-6) have been consistently observed in patients with Alzheimer's disease (AD) compared to healthy controls (Iulita et al. 2016). The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.